Targeting monocytes/macrophages in the treatment of rheumatoid arthritis

Biotherapies have revolutionized the treatment of RA. However, much work is needed to understand all the mechanisms of these biotherapies, and alternatives are needed to circumvent adverse effects and the high cost of these long-lasting treatments. In this article we outline some of the approaches w...

Full description

Saved in:
Bibliographic Details
Published in:Rheumatology (Oxford, England) England), 2013-04, Vol.52 (4), p.590-598
Main Authors: Davignon, Jean-Luc, Hayder, Myriam, Baron, Michel, Boyer, Jean-Frédéric, Constantin, Arnaud, Apparailly, Florence, Poupot, Rémy, Cantagrel, Alain
Format: Article
Language:English
Subjects:
Animals
Arthritis, Rheumatoid - immunology
Arthritis, Rheumatoid - therapy
Dendrimers
Gene Silencing - drug effects
Group IV Phospholipases A2 - genetics
Humans
Macrophages - enzymology
Molecular Targeted Therapy - methods
Monocytes - enzymology
RNA, Small Interfering - therapeutic use
Tumor Necrosis Factor-alpha - immunology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c416t-85bed37061a2b50b6c3ecff8952af358d7a96c2b3b5334e846d825388c9325e63
cites cdi_FETCH-LOGICAL-c416t-85bed37061a2b50b6c3ecff8952af358d7a96c2b3b5334e846d825388c9325e63
container_end_page 598
container_issue 4
container_start_page 590
container_title Rheumatology (Oxford, England)
container_volume 52
creator Davignon, Jean-Luc
Hayder, Myriam
Baron, Michel
Boyer, Jean-Frédéric
Constantin, Arnaud
Apparailly, Florence
Poupot, Rémy
Cantagrel, Alain
description Biotherapies have revolutionized the treatment of RA. However, much work is needed to understand all the mechanisms of these biotherapies, and alternatives are needed to circumvent adverse effects and the high cost of these long-lasting treatments. In this article we outline some of the approaches we have used to target monocytes/macrophages as major components of inflammation and bone homeostasis. We also discuss how anti-TNF-α antibodies target monocytes/macrophages in the complex mechanisms contributing to inhibition of inflammation.
doi_str_mv 10.1093/rheumatology/kes304
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1319175028</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1319175028</sourcerecordid><originalsourceid>FETCH-LOGICAL-c416t-85bed37061a2b50b6c3ecff8952af358d7a96c2b3b5334e846d825388c9325e63</originalsourceid><addsrcrecordid>eNpNkEtPwzAQhC0EoqXwC5BQjlxCba-dOkdUAUWqxKWcI8fZPCCOi-0c-u8p6kOcZg8zO5qPkHtGnxjNYe5bHK2OrnfNbv6NAai4IFMmMp5SAH55vrmYkJsQviilkoG6JhMOnAop2ZSsNto3GLuhSawbnNlFDHOrjXfbVjcYkm5IYotJ9KijxSEmrk5OzV2VaB9b38Uu3JKrWvcB7446I5-vL5vlKl1_vL0vn9epESyLqZIlVrCgGdO8lLTMDKCpa5VLrmuQqlroPDO8hFICCFQiqxSXoJTJgUvMYEYeD3-33v2MGGJhu2Cw7_WAbgwFA5azhaRc7a1wsO7XhOCxLra-s9rvCkaLP4TFf4TFAeE-9XAsGEuL1TlzYga_UdZyaQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1319175028</pqid></control><display><type>article</type><title>Targeting monocytes/macrophages in the treatment of rheumatoid arthritis</title><source>Oxford Journals Online</source><source>Alma/SFX Local Collection</source><creator>Davignon, Jean-Luc ; Hayder, Myriam ; Baron, Michel ; Boyer, Jean-Frédéric ; Constantin, Arnaud ; Apparailly, Florence ; Poupot, Rémy ; Cantagrel, Alain</creator><creatorcontrib>Davignon, Jean-Luc ; Hayder, Myriam ; Baron, Michel ; Boyer, Jean-Frédéric ; Constantin, Arnaud ; Apparailly, Florence ; Poupot, Rémy ; Cantagrel, Alain</creatorcontrib><description>Biotherapies have revolutionized the treatment of RA. However, much work is needed to understand all the mechanisms of these biotherapies, and alternatives are needed to circumvent adverse effects and the high cost of these long-lasting treatments. In this article we outline some of the approaches we have used to target monocytes/macrophages as major components of inflammation and bone homeostasis. We also discuss how anti-TNF-α antibodies target monocytes/macrophages in the complex mechanisms contributing to inhibition of inflammation.</description><identifier>ISSN: 1462-0324</identifier><identifier>EISSN: 1462-0332</identifier><identifier>DOI: 10.1093/rheumatology/kes304</identifier><identifier>PMID: 23204551</identifier><language>eng</language><publisher>England</publisher><subject>Animals ; Arthritis, Rheumatoid - immunology ; Arthritis, Rheumatoid - therapy ; Dendrimers ; Gene Silencing - drug effects ; Group IV Phospholipases A2 - genetics ; Humans ; Macrophages - enzymology ; Molecular Targeted Therapy - methods ; Monocytes - enzymology ; RNA, Small Interfering - therapeutic use ; Tumor Necrosis Factor-alpha - immunology</subject><ispartof>Rheumatology (Oxford, England), 2013-04, Vol.52 (4), p.590-598</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c416t-85bed37061a2b50b6c3ecff8952af358d7a96c2b3b5334e846d825388c9325e63</citedby><cites>FETCH-LOGICAL-c416t-85bed37061a2b50b6c3ecff8952af358d7a96c2b3b5334e846d825388c9325e63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23204551$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Davignon, Jean-Luc</creatorcontrib><creatorcontrib>Hayder, Myriam</creatorcontrib><creatorcontrib>Baron, Michel</creatorcontrib><creatorcontrib>Boyer, Jean-Frédéric</creatorcontrib><creatorcontrib>Constantin, Arnaud</creatorcontrib><creatorcontrib>Apparailly, Florence</creatorcontrib><creatorcontrib>Poupot, Rémy</creatorcontrib><creatorcontrib>Cantagrel, Alain</creatorcontrib><title>Targeting monocytes/macrophages in the treatment of rheumatoid arthritis</title><title>Rheumatology (Oxford, England)</title><addtitle>Rheumatology (Oxford)</addtitle><description>Biotherapies have revolutionized the treatment of RA. However, much work is needed to understand all the mechanisms of these biotherapies, and alternatives are needed to circumvent adverse effects and the high cost of these long-lasting treatments. In this article we outline some of the approaches we have used to target monocytes/macrophages as major components of inflammation and bone homeostasis. We also discuss how anti-TNF-α antibodies target monocytes/macrophages in the complex mechanisms contributing to inhibition of inflammation.</description><subject>Animals</subject><subject>Arthritis, Rheumatoid - immunology</subject><subject>Arthritis, Rheumatoid - therapy</subject><subject>Dendrimers</subject><subject>Gene Silencing - drug effects</subject><subject>Group IV Phospholipases A2 - genetics</subject><subject>Humans</subject><subject>Macrophages - enzymology</subject><subject>Molecular Targeted Therapy - methods</subject><subject>Monocytes - enzymology</subject><subject>RNA, Small Interfering - therapeutic use</subject><subject>Tumor Necrosis Factor-alpha - immunology</subject><issn>1462-0324</issn><issn>1462-0332</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNpNkEtPwzAQhC0EoqXwC5BQjlxCba-dOkdUAUWqxKWcI8fZPCCOi-0c-u8p6kOcZg8zO5qPkHtGnxjNYe5bHK2OrnfNbv6NAai4IFMmMp5SAH55vrmYkJsQviilkoG6JhMOnAop2ZSsNto3GLuhSawbnNlFDHOrjXfbVjcYkm5IYotJ9KijxSEmrk5OzV2VaB9b38Uu3JKrWvcB7446I5-vL5vlKl1_vL0vn9epESyLqZIlVrCgGdO8lLTMDKCpa5VLrmuQqlroPDO8hFICCFQiqxSXoJTJgUvMYEYeD3-33v2MGGJhu2Cw7_WAbgwFA5azhaRc7a1wsO7XhOCxLra-s9rvCkaLP4TFf4TFAeE-9XAsGEuL1TlzYga_UdZyaQ</recordid><startdate>20130401</startdate><enddate>20130401</enddate><creator>Davignon, Jean-Luc</creator><creator>Hayder, Myriam</creator><creator>Baron, Michel</creator><creator>Boyer, Jean-Frédéric</creator><creator>Constantin, Arnaud</creator><creator>Apparailly, Florence</creator><creator>Poupot, Rémy</creator><creator>Cantagrel, Alain</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20130401</creationdate><title>Targeting monocytes/macrophages in the treatment of rheumatoid arthritis</title><author>Davignon, Jean-Luc ; Hayder, Myriam ; Baron, Michel ; Boyer, Jean-Frédéric ; Constantin, Arnaud ; Apparailly, Florence ; Poupot, Rémy ; Cantagrel, Alain</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c416t-85bed37061a2b50b6c3ecff8952af358d7a96c2b3b5334e846d825388c9325e63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Animals</topic><topic>Arthritis, Rheumatoid - immunology</topic><topic>Arthritis, Rheumatoid - therapy</topic><topic>Dendrimers</topic><topic>Gene Silencing - drug effects</topic><topic>Group IV Phospholipases A2 - genetics</topic><topic>Humans</topic><topic>Macrophages - enzymology</topic><topic>Molecular Targeted Therapy - methods</topic><topic>Monocytes - enzymology</topic><topic>RNA, Small Interfering - therapeutic use</topic><topic>Tumor Necrosis Factor-alpha - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Davignon, Jean-Luc</creatorcontrib><creatorcontrib>Hayder, Myriam</creatorcontrib><creatorcontrib>Baron, Michel</creatorcontrib><creatorcontrib>Boyer, Jean-Frédéric</creatorcontrib><creatorcontrib>Constantin, Arnaud</creatorcontrib><creatorcontrib>Apparailly, Florence</creatorcontrib><creatorcontrib>Poupot, Rémy</creatorcontrib><creatorcontrib>Cantagrel, Alain</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Rheumatology (Oxford, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Davignon, Jean-Luc</au><au>Hayder, Myriam</au><au>Baron, Michel</au><au>Boyer, Jean-Frédéric</au><au>Constantin, Arnaud</au><au>Apparailly, Florence</au><au>Poupot, Rémy</au><au>Cantagrel, Alain</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Targeting monocytes/macrophages in the treatment of rheumatoid arthritis</atitle><jtitle>Rheumatology (Oxford, England)</jtitle><addtitle>Rheumatology (Oxford)</addtitle><date>2013-04-01</date><risdate>2013</risdate><volume>52</volume><issue>4</issue><spage>590</spage><epage>598</epage><pages>590-598</pages><issn>1462-0324</issn><eissn>1462-0332</eissn><abstract>Biotherapies have revolutionized the treatment of RA. However, much work is needed to understand all the mechanisms of these biotherapies, and alternatives are needed to circumvent adverse effects and the high cost of these long-lasting treatments. In this article we outline some of the approaches we have used to target monocytes/macrophages as major components of inflammation and bone homeostasis. We also discuss how anti-TNF-α antibodies target monocytes/macrophages in the complex mechanisms contributing to inhibition of inflammation.</abstract><cop>England</cop><pmid>23204551</pmid><doi>10.1093/rheumatology/kes304</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1462-0324
ispartof Rheumatology (Oxford, England), 2013-04, Vol.52 (4), p.590-598
issn 1462-0324
1462-0332
language eng
recordid cdi_proquest_miscellaneous_1319175028
source Oxford Journals Online; Alma/SFX Local Collection
subjects Animals
Arthritis, Rheumatoid - immunology
Arthritis, Rheumatoid - therapy
Dendrimers
Gene Silencing - drug effects
Group IV Phospholipases A2 - genetics
Humans
Macrophages - enzymology
Molecular Targeted Therapy - methods
Monocytes - enzymology
RNA, Small Interfering - therapeutic use
Tumor Necrosis Factor-alpha - immunology
title Targeting monocytes/macrophages in the treatment of rheumatoid arthritis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T16%3A58%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Targeting%20monocytes/macrophages%20in%20the%20treatment%20of%20rheumatoid%20arthritis&rft.jtitle=Rheumatology%20(Oxford,%20England)&rft.au=Davignon,%20Jean-Luc&rft.date=2013-04-01&rft.volume=52&rft.issue=4&rft.spage=590&rft.epage=598&rft.pages=590-598&rft.issn=1462-0324&rft.eissn=1462-0332&rft_id=info:doi/10.1093/rheumatology/kes304&rft_dat=%3Cproquest_cross%3E1319175028%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c416t-85bed37061a2b50b6c3ecff8952af358d7a96c2b3b5334e846d825388c9325e63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1319175028&rft_id=info:pmid/23204551&rfr_iscdi=true